MYLK2 and prostate adenocarcinoma: We confirmed that MYLK2 was highly expressed in PRAD by qPCR of normal prostate epithelial cell line RWPE-1 as well as prostate cancer cell lines PC-3 and LNCaP clone FGC, and Western blotting (WB).